Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J1306 |
Short Description | Injection, inclisiran, 1 mg |
Long Description | Injection, inclisiran, 1 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2022-07-01 |
Date Added | 2022-07-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
00078100060 | J1306 | Injection, inclisiran, 1 mg | Leqvio | NOVARTIS PHARMACEUTICALS CORP. | 1 MG | 1.5 | 1 | 284 | 284 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 1 MG |
HCPCS/CPT Billing Units | 1 |
Total doses ordered | |
Billing Units | 1 |
Drug Details
-
Inclisiran injection is used along with diet alone or in combination with other cholesterol-lowering medications to decrease the amount of low-density lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood in people with familial heterozygous hypercholesterolemia (HeFH) (an inherited condition in which cholesterol cannot be removed from the body normally). It is also used along with diet changes and other treatments to reduce the amount of low-density lipoprotein (LDL) cholesterol ('bad cholesterol') in the blood in people who have clinical atherosclerotic cardiovascular disease (ASCVD). Inclisiran injection is in a class of medications called proprotein convertase subtilisin kexin type 9 (PCSK9)-interfering mRNA. It works by decreasing the amount of LDL cholesterol in the blood to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body.